Pharmacological and clinical profile of gilteritinib (Xospata&lt;sup&gt;®&lt;/sup&gt; tablets 40 mg), a therapeutic agent for relapsed or refractory &lt;i&gt;FLT3&lt;/i&gt;-mutated acute myeloid leukemia
Nihon Yakurigaku zasshi/Nihon yakurigaku zasshi